Regulation of mir-196b by MLL and its overexpression by MLL fusions contributes to immortalizationRelja Popovic, Nancy J. Zeleznik‐Le, Jun Lü et al.|Blood|2009Cited by 220
Identification of recurrent genomic alterations in the apoptotic machinery in chronic lymphocytic leukemia patients treated with venetoclax monotherapyRelja Popovic, Brenda Chyla, Fengjiao Dunbar et al.|American Journal of Hematology|2021Cited by 19
Pooled Multi-Trial Analysis of Venetoclax Efficacy in Patients with Relapsed or Refractory Chronic Lymphocytic LeukemiaAndrew W. Roberts, Michael Hallek, John F. Seymour et al.|Blood|2016Cited by 14
Six-year follow-up and subgroup analyses of a phase 2 trial of venetoclax for del(17p) chronic lymphocytic leukemiaStephan Stilgenbauer, John F. Seymour, Eugen Tausch et al.|Blood Advances|2024Cited by 13